HEADER NUCLEAR RECEPTOR 05-AUG-99 1QKU TITLE WILD TYPE ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED TITLE 2 WITH ESTRADIOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTRADIOL RECEPTOR; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELLULAR_LOCATION: NUCLEUS; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_CELLULAR_LOCATION: CYTOPLASM; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15 KEYWDS NUCLEAR RECEPTOR, AGONISM, ANTAGONISM, ESTRADIOL RECEPTOR, STEROID, KEYWDS 2 STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS EXPDTA X-RAY DIFFRACTION AUTHOR M.RUFF,M.GANGLOFF,S.EILER,S.DUCLAUD,J.M.WURTZ,D.MORAS REVDAT 3 28-FEB-18 1QKU 1 SOURCE JRNL REVDAT 2 24-FEB-09 1QKU 1 VERSN REVDAT 1 18-AUG-00 1QKU 0 JRNL AUTH M.GANGLOFF,M.RUFF,S.EILER,S.DUCLAUD,J.M.WURTZ,D.MORAS JRNL TITL CRYSTAL STRUCTURE OF A MUTANT HERALPHA LIGAND-BINDING DOMAIN JRNL TITL 2 REVEALS KEY STRUCTURAL FEATURES FOR THE MECHANISM OF PARTIAL JRNL TITL 3 AGONISM. JRNL REF J. BIOL. CHEM. V. 276 15059 2001 JRNL REFN ISSN 0021-9258 JRNL PMID 11278577 JRNL DOI 10.1074/JBC.M009870200 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.4 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2087323.510 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.9 REMARK 3 NUMBER OF REFLECTIONS : 13994 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.275 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.700 REMARK 3 FREE R VALUE TEST SET COUNT : 1357 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.40 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1949 REMARK 3 BIN R VALUE (WORKING SET) : 0.3030 REMARK 3 BIN FREE R VALUE : 0.3720 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 195 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.027 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5940 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 596 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 60.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 20.84000 REMARK 3 B22 (A**2) : 20.84000 REMARK 3 B33 (A**2) : -41.68000 REMARK 3 B12 (A**2) : 0.66000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM SIGMAA (A) : 0.51 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.48 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.64 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.790 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.670 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.880 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.230 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.570 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.23 REMARK 3 BSOL : 12.98 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ESTRADIOL.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ESTRADIOL.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1QKU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-AUG-99. REMARK 100 THE DEPOSITION ID IS D_1290003008. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 110.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19255 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08000 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS 0.4 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 90.72000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 45.36000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 45.36000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 90.72000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS 2 INDEPENDENT REMARK 300 MOLECULES.CHAINS B AND C MAKE ONE HOMO-DIMER REMARK 300 WITH CHAIN ACONSISTING OF ONE HALF OF A SECOND REMARK 300 DIMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 8360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25340 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 45.36000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 8680 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24790 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER B 301 REMARK 465 LYS B 302 REMARK 465 LYS B 303 REMARK 465 SER C 301 REMARK 465 LYS C 302 REMARK 465 LYS C 303 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 301 OG REMARK 470 LYS A 302 CG CD CE NZ REMARK 470 LYS A 303 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2040 O HOH A 2161 2.12 REMARK 500 O ILE B 487 O HOH B 2152 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG C 548 NE - CZ - NH2 ANGL. DEV. = 3.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 303 -179.82 -60.69 REMARK 500 SER A 305 -140.04 -85.94 REMARK 500 LEU A 310 140.00 -33.07 REMARK 500 VAL A 316 -70.13 -63.25 REMARK 500 SER A 317 -14.74 -49.62 REMARK 500 GLU A 323 137.12 -34.82 REMARK 500 LEU A 327 -171.32 -62.30 REMARK 500 PRO A 333 21.62 -56.15 REMARK 500 THR A 334 -83.51 -93.13 REMARK 500 HIS A 398 73.78 -107.66 REMARK 500 PHE A 445 -71.74 -45.42 REMARK 500 SER A 464 26.42 -158.72 REMARK 500 THR A 465 -131.94 -86.45 REMARK 500 LEU A 495 131.55 -31.55 REMARK 500 ASP A 545 9.78 -66.87 REMARK 500 ARG A 548 12.19 50.06 REMARK 500 LEU B 306 15.89 -64.27 REMARK 500 VAL B 316 -70.78 -61.95 REMARK 500 SER B 317 -13.76 -49.49 REMARK 500 GLU B 323 136.68 -33.67 REMARK 500 ILE B 326 43.27 -94.76 REMARK 500 LEU B 327 133.67 -23.09 REMARK 500 TYR B 331 132.83 -179.21 REMARK 500 PRO B 333 12.71 -56.78 REMARK 500 ARG B 335 117.78 -168.19 REMARK 500 HIS B 398 73.77 -106.57 REMARK 500 PHE B 445 -70.29 -47.02 REMARK 500 LYS B 492 19.55 -67.49 REMARK 500 ALA B 493 17.42 -145.90 REMARK 500 ASP B 545 9.28 -67.52 REMARK 500 ARG B 548 12.20 50.24 REMARK 500 VAL C 316 -70.16 -61.84 REMARK 500 SER C 317 -14.94 -49.95 REMARK 500 GLU C 323 135.88 -33.31 REMARK 500 ILE C 326 66.34 -102.70 REMARK 500 SER C 329 -143.54 -106.18 REMARK 500 GLU C 330 35.45 -159.07 REMARK 500 THR C 334 -81.49 -59.54 REMARK 500 PRO C 336 160.23 -49.40 REMARK 500 HIS C 398 73.60 -107.04 REMARK 500 PHE C 445 -70.74 -45.81 REMARK 500 THR C 465 -153.59 -77.31 REMARK 500 LEU C 489 -19.72 -47.50 REMARK 500 LYS C 492 20.42 -68.60 REMARK 500 ALA C 493 24.97 -143.27 REMARK 500 ASP C 545 9.48 -67.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2083 DISTANCE = 6.73 ANGSTROMS REMARK 525 HOH B2080 DISTANCE = 7.11 ANGSTROMS REMARK 525 HOH B2088 DISTANCE = 6.18 ANGSTROMS REMARK 525 HOH B2138 DISTANCE = 6.20 ANGSTROMS REMARK 525 HOH B2147 DISTANCE = 7.25 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EST A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EST B 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EST C 600 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1QKU RELATED DB: PDB REMARK 900 MUTANT ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED REMARK 900 WITH ESTRADIOL REMARK 900 RELATED ID: 1HCP RELATED DB: PDB REMARK 900 HUMAN/CHICKEN ESTROGEN RECEPTOR REMARK 900 RELATED ID: 1HCQ RELATED DB: PDB REMARK 900 HUMAN/CHICKEN ESTROGEN RECEPTOR REMARK 900 RELATED ID: 1AKF RELATED DB: PDB REMARK 900 HOMOLOGOUS-EXTENSION-BASED MODEL OF HUMAN ESTROGEN RECEPTOR WITH REMARK 900 BOUND ESTRADIOL, THEORETICAL MODEL REMARK 900 RELATED ID: 1A52 RELATED DB: PDB REMARK 900 ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO ESTRADIOL REMARK 900 RELATED ID: 1ERE RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 17BETA-ESTRADIOL REMARK 900 RELATED ID: 1ERR RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 RALOXIFENE REMARK 900 RELATED ID: 3ERD RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 DIETHYLSTILBESTROL AND A GLUCOCORTICOID RECEPTOR INTERACTING REMARK 900 PROTEIN 1 NR BOX II PEPTIDE REMARK 900 RELATED ID: 3ERT RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 4-HYDROXYTAMOXIFEN REMARK 900 RELATED ID: 1QKM RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 PARTIAL AGONIST GENISTEIN REMARK 900 RELATED ID: 1QKN RELATED DB: PDB REMARK 900 RAT ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 ANTAGONIST RALOXIFENE DBREF 1QKU A 301 550 UNP P03372 ESR1_HUMAN 301 550 DBREF 1QKU B 301 550 UNP P03372 ESR1_HUMAN 301 550 DBREF 1QKU C 301 550 UNP P03372 ESR1_HUMAN 301 550 SEQRES 1 A 250 SER LYS LYS ASN SER LEU ALA LEU SER LEU THR ALA ASP SEQRES 2 A 250 GLN MET VAL SER ALA LEU LEU ASP ALA GLU PRO PRO ILE SEQRES 3 A 250 LEU TYR SER GLU TYR ASP PRO THR ARG PRO PHE SER GLU SEQRES 4 A 250 ALA SER MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG SEQRES 5 A 250 GLU LEU VAL HIS MET ILE ASN TRP ALA LYS ARG VAL PRO SEQRES 6 A 250 GLY PHE VAL ASP LEU THR LEU HIS ASP GLN VAL HIS LEU SEQRES 7 A 250 LEU GLU CYS ALA TRP LEU GLU ILE LEU MET ILE GLY LEU SEQRES 8 A 250 VAL TRP ARG SER MET GLU HIS PRO GLY LYS LEU LEU PHE SEQRES 9 A 250 ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS CYS SEQRES 10 A 250 VAL GLU GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA SEQRES 11 A 250 THR SER SER ARG PHE ARG MET MET ASN LEU GLN GLY GLU SEQRES 12 A 250 GLU PHE VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SER SEQRES 13 A 250 GLY VAL TYR THR PHE LEU SER SER THR LEU LYS SER LEU SEQRES 14 A 250 GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE SEQRES 15 A 250 THR ASP THR LEU ILE HIS LEU MET ALA LYS ALA GLY LEU SEQRES 16 A 250 THR LEU GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU SEQRES 17 A 250 LEU ILE LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY SEQRES 18 A 250 MET GLU HIS LEU TYR SER MET LYS CYS LYS ASN VAL VAL SEQRES 19 A 250 PRO LEU TYR ASP LEU LEU LEU GLU MET LEU ASP ALA HIS SEQRES 20 A 250 ARG LEU HIS SEQRES 1 B 250 SER LYS LYS ASN SER LEU ALA LEU SER LEU THR ALA ASP SEQRES 2 B 250 GLN MET VAL SER ALA LEU LEU ASP ALA GLU PRO PRO ILE SEQRES 3 B 250 LEU TYR SER GLU TYR ASP PRO THR ARG PRO PHE SER GLU SEQRES 4 B 250 ALA SER MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG SEQRES 5 B 250 GLU LEU VAL HIS MET ILE ASN TRP ALA LYS ARG VAL PRO SEQRES 6 B 250 GLY PHE VAL ASP LEU THR LEU HIS ASP GLN VAL HIS LEU SEQRES 7 B 250 LEU GLU CYS ALA TRP LEU GLU ILE LEU MET ILE GLY LEU SEQRES 8 B 250 VAL TRP ARG SER MET GLU HIS PRO GLY LYS LEU LEU PHE SEQRES 9 B 250 ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS CYS SEQRES 10 B 250 VAL GLU GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA SEQRES 11 B 250 THR SER SER ARG PHE ARG MET MET ASN LEU GLN GLY GLU SEQRES 12 B 250 GLU PHE VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SER SEQRES 13 B 250 GLY VAL TYR THR PHE LEU SER SER THR LEU LYS SER LEU SEQRES 14 B 250 GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE SEQRES 15 B 250 THR ASP THR LEU ILE HIS LEU MET ALA LYS ALA GLY LEU SEQRES 16 B 250 THR LEU GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU SEQRES 17 B 250 LEU ILE LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY SEQRES 18 B 250 MET GLU HIS LEU TYR SER MET LYS CYS LYS ASN VAL VAL SEQRES 19 B 250 PRO LEU TYR ASP LEU LEU LEU GLU MET LEU ASP ALA HIS SEQRES 20 B 250 ARG LEU HIS SEQRES 1 C 250 SER LYS LYS ASN SER LEU ALA LEU SER LEU THR ALA ASP SEQRES 2 C 250 GLN MET VAL SER ALA LEU LEU ASP ALA GLU PRO PRO ILE SEQRES 3 C 250 LEU TYR SER GLU TYR ASP PRO THR ARG PRO PHE SER GLU SEQRES 4 C 250 ALA SER MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG SEQRES 5 C 250 GLU LEU VAL HIS MET ILE ASN TRP ALA LYS ARG VAL PRO SEQRES 6 C 250 GLY PHE VAL ASP LEU THR LEU HIS ASP GLN VAL HIS LEU SEQRES 7 C 250 LEU GLU CYS ALA TRP LEU GLU ILE LEU MET ILE GLY LEU SEQRES 8 C 250 VAL TRP ARG SER MET GLU HIS PRO GLY LYS LEU LEU PHE SEQRES 9 C 250 ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS CYS SEQRES 10 C 250 VAL GLU GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA SEQRES 11 C 250 THR SER SER ARG PHE ARG MET MET ASN LEU GLN GLY GLU SEQRES 12 C 250 GLU PHE VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SER SEQRES 13 C 250 GLY VAL TYR THR PHE LEU SER SER THR LEU LYS SER LEU SEQRES 14 C 250 GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE SEQRES 15 C 250 THR ASP THR LEU ILE HIS LEU MET ALA LYS ALA GLY LEU SEQRES 16 C 250 THR LEU GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU SEQRES 17 C 250 LEU ILE LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY SEQRES 18 C 250 MET GLU HIS LEU TYR SER MET LYS CYS LYS ASN VAL VAL SEQRES 19 C 250 PRO LEU TYR ASP LEU LEU LEU GLU MET LEU ASP ALA HIS SEQRES 20 C 250 ARG LEU HIS HET EST A 600 20 HET EST B 600 20 HET EST C 600 20 HETNAM EST ESTRADIOL FORMUL 4 EST 3(C18 H24 O2) FORMUL 7 HOH *596(H2 O) HELIX 1 1 THR A 311 GLU A 323 1 13 HELIX 2 2 SER A 338 VAL A 364 1 27 HELIX 3 3 GLY A 366 LEU A 370 5 5 HELIX 4 4 THR A 371 SER A 395 1 25 HELIX 5 5 ASN A 413 VAL A 418 5 6 HELIX 6 6 GLY A 420 MET A 438 1 19 HELIX 7 7 GLN A 441 SER A 456 1 16 HELIX 8 8 LEU A 466 LYS A 492 1 27 HELIX 9 9 THR A 496 LYS A 531 1 36 HELIX 10 10 TYR A 537 MET A 543 1 7 HELIX 11 11 THR B 311 GLU B 323 1 13 HELIX 12 12 SER B 338 VAL B 364 1 27 HELIX 13 13 GLY B 366 LEU B 370 5 5 HELIX 14 14 THR B 371 SER B 395 1 25 HELIX 15 15 ARG B 412 LYS B 416 1 5 HELIX 16 16 GLY B 420 MET B 438 1 19 HELIX 17 17 GLN B 441 SER B 456 1 16 HELIX 18 18 LEU B 466 LYS B 492 1 27 HELIX 19 19 THR B 496 LYS B 531 1 36 HELIX 20 20 TYR B 537 MET B 543 1 7 HELIX 21 21 SER C 305 SER C 309 5 5 HELIX 22 22 THR C 311 GLU C 323 1 13 HELIX 23 23 SER C 338 VAL C 364 1 27 HELIX 24 24 GLY C 366 LEU C 370 5 5 HELIX 25 25 THR C 371 SER C 395 1 25 HELIX 26 26 ASN C 413 VAL C 418 5 6 HELIX 27 27 GLY C 420 MET C 438 1 19 HELIX 28 28 GLN C 441 SER C 456 1 16 HELIX 29 29 LEU C 466 LYS C 492 1 27 HELIX 30 30 THR C 496 LYS C 531 1 36 HELIX 31 31 TYR C 537 MET C 543 1 7 SHEET 1 A 2 LYS A 401 LEU A 402 0 SHEET 2 A 2 LEU A 410 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 B 2 LYS B 401 LEU B 402 0 SHEET 2 B 2 LEU B 410 ASP B 411 -1 O LEU B 410 N LEU B 402 SHEET 1 C 2 LYS C 401 LEU C 402 0 SHEET 2 C 2 LEU C 410 ASP C 411 -1 O LEU C 410 N LEU C 402 SITE 1 AC1 10 GLU A 353 LEU A 387 MET A 388 ARG A 394 SITE 2 AC1 10 PHE A 404 MET A 421 ILE A 424 GLY A 521 SITE 3 AC1 10 HIS A 524 LEU A 525 SITE 1 AC2 11 GLU B 353 LEU B 387 MET B 388 LEU B 391 SITE 2 AC2 11 ARG B 394 PHE B 404 MET B 421 ILE B 424 SITE 3 AC2 11 GLY B 521 HIS B 524 LEU B 525 SITE 1 AC3 11 GLU C 353 LEU C 387 MET C 388 LEU C 391 SITE 2 AC3 11 ARG C 394 PHE C 404 MET C 421 ILE C 424 SITE 3 AC3 11 GLY C 521 HIS C 524 LEU C 525 CRYST1 105.500 105.500 136.080 90.00 90.00 120.00 P 32 2 1 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009479 0.005472 0.000000 0.00000 SCALE2 0.000000 0.010945 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007349 0.00000